NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +168 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Stage IV Cervical Cancer AJCC v8
Explore clinical trials studying Stage IV Cervical Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
11 public trials
5 recruiting studies
Stage IV Cervical Cancer AJCC v8 trial results
NCT07741968
- Conditions
- Adnexal Diseases, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +44 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- City of Hope at Arcadia Arcadia, California, United States
- City of Hope at Seacliff Huntington Beach, California, United States
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
NCT03968406
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +46 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT04723095
- Conditions
- Cervical Large Cell Neuroendocrine Carcinoma, Cervical Neuroendocrine Carcinoma, Cervical Small Cell Carcinoma, +32 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
NCT07576725
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
- Locations
-
- Uganda Cancer Institute Kampala, Uganda
Active, not recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
NCT04491942
- Conditions
- Adenoma, Adnexal Diseases, Advanced Bile Duct Carcinoma, +72 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
Active, not recruiting
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
NCT05786456
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +31 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +213 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT03452332
- Conditions
- Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, +50 more
- Locations
-
- UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States
- M D Anderson Cancer Center Houston, Texas, United States